Corporate

B. Braun Melsungen AG

In November 2015, Trendlines entered into a memorandum of understanding with B. Braun Melsungen AG, one of the world’s leading health care suppliers. In accordance with the agreement, Trendlines and B. Braun cooperate for mutual deal flow, identification of new investments, working together in the establishment of incubators, and collaboration in the development of new technologies, solutions, and products.

Visit B. Braun’s Corporate Investment & Collaborations page.

B. Braun’s four divisions focus products and services toward different medical fields: hospital, surgery, private practice (medical care and doctors’ offices), and extracorporeal blood treatment.

• In November 2014, B. Braun Medical SAS, a B. Braun company, acquired the assets of Trendlines’ portfolio company Stimatix.
• B. Braun subscribed to Trendlines IPO in November 2015 for $5 million as a cornerstone investor.
• In September 2016, B. Braun invested in Trendlines Medical Singapore.
• The Trendlines-B. Braun partnership led to a $5 million investment for ApiFix in November 2016.
• In December 2016, B. Braun led a funding round, investing €1 million in portfolio company Gordian Surgical.
• In September 2017, Fidmi Medical announced that it received an investment of $2 million from B. Braun.

Our investment in Trendlines Medical Singapore signifies our commitment to making a significant contribution to medical advancements by promoting the development of new medical products and technologies that meet the challenges in today’s complex health care landscape and allow us to share expertise.

—Anna Maria Braun, President of B. Braun Asia Pacific and a member of the B. Braun management board